The reelin gene (RELN) has been proposed as a risk gene implicated in several psychiatric disorders, including schizophrenia (Beasley et al., 2020), depression (Caruncho et al., 2016), and autism spectrum disorders (Aldinger et al., 2011). This evidence concerns the gene RELN and depressive symptom measurement.